Adding a new medication to existing arthritis treatment for better control

This trial is testing whether adding deucravacitinib to your current psoriatic arthritis treatment can help control your symptoms better. The study combines deucravacitinib—a new oral medication—with the anti-TNF injection you may already be taking to see if this combination works better than the injection alone. The goal is to give you better relief with manageable side effects.

Many people with psoriatic arthritis don't get enough symptom relief from current treatments alone. This study explores whether using two different types of medications together—targeting different parts of the disease—might offer better control than one treatment by itself.